Drugs / DTaP vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT02458183 Comparator | Feb 2015 → Dec 2017 | diphtheria, pertussis, poliomyelitis, tetanus | Boryung Pharmaceutical Co., Ltd | Completed | No outcome recorded |
| Phase 3 | NCT00319852 Comparator | Apr 2006 → Apr 2008 | diphtheria, pertussis, poliomyelitis, tetanus | Sanofi | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTaP vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00319852 ↗ |
| Known as | DTaP vaccine (CJ purified PDT vaccine ) | “DTaP vaccine (CJ purified PDT vaccine ™)” NCT00319852 ↗ |
| Modality | Vaccine | “DTaP vaccine” NCT00319852 ↗ |
| Route | Intramuscular | “0.5 mL, IM” NCT00319852 ↗ |